Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”

Detalles Bibliográficos
Autores principales: Sookaromdee, Pathum, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578334/
https://www.ncbi.nlm.nih.gov/pubmed/36270936
http://dx.doi.org/10.1016/j.dld.2022.09.014
_version_ 1784811949855342592
author Sookaromdee, Pathum
Wiwanitkit, Viroj
author_facet Sookaromdee, Pathum
Wiwanitkit, Viroj
author_sort Sookaromdee, Pathum
collection PubMed
description
format Online
Article
Text
id pubmed-9578334
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-95783342022-10-18 Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study” Sookaromdee, Pathum Wiwanitkit, Viroj Dig Liver Dis Correspondence Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2023-01 2022-10-18 /pmc/articles/PMC9578334/ /pubmed/36270936 http://dx.doi.org/10.1016/j.dld.2022.09.014 Text en © 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Sookaromdee, Pathum
Wiwanitkit, Viroj
Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
title Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
title_full Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
title_fullStr Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
title_full_unstemmed Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
title_short Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
title_sort comment on: “reduced humoral response to two doses of covid-19 vaccine in patients with inflammatory bowel disease: data from escape-ibd, an ig-ibd study”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578334/
https://www.ncbi.nlm.nih.gov/pubmed/36270936
http://dx.doi.org/10.1016/j.dld.2022.09.014
work_keys_str_mv AT sookaromdeepathum commentonreducedhumoralresponsetotwodosesofcovid19vaccineinpatientswithinflammatoryboweldiseasedatafromescapeibdanigibdstudy
AT wiwanitkitviroj commentonreducedhumoralresponsetotwodosesofcovid19vaccineinpatientswithinflammatoryboweldiseasedatafromescapeibdanigibdstudy

Ejemplares similares